399 related articles for article (PubMed ID: 33733634)
1. Biomarkers for Severe Asthma: Lessons From Longitudinal Cohort Studies.
Lee Y; Quoc QL; Park HS
Allergy Asthma Immunol Res; 2021 May; 13(3):375-389. PubMed ID: 33733634
[TBL] [Abstract][Full Text] [Related]
2. Treatment Resistance in Severe Asthma Patients With a Combination of High Fraction of Exhaled Nitric Oxide and Low Blood Eosinophil Counts.
Hoshino Y; Soma T; Uchida Y; Shiko Y; Nakagome K; Nagata M
Front Pharmacol; 2022; 13():836635. PubMed ID: 35517829
[No Abstract] [Full Text] [Related]
3. Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma.
Soma T; Iemura H; Naito E; Miyauchi S; Uchida Y; Nakagome K; Nagata M
Allergol Int; 2018 Sep; 67S():S3-S11. PubMed ID: 29754974
[TBL] [Abstract][Full Text] [Related]
4. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects.
Hastie AT; Moore WC; Li H; Rector BM; Ortega VE; Pascual RM; Peters SP; Meyers DA; Bleecker ER;
J Allergy Clin Immunol; 2013 Jul; 132(1):72-80. PubMed ID: 23706399
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of IL-5, IL-6, IL-8, IL-13 and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma.
Dimitrova D; Youroukova V; Ivanova-Todorova E; Tumangelova-Yuzeir K; Velikova T
Respir Med; 2019; 154():144-154. PubMed ID: 31260861
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers in asthma, potential for therapeutic intervention.
Pasha MA; Hopp RJ; Habib N; Tang DD
J Asthma; 2024 Jun; ():1-16. PubMed ID: 38805392
[TBL] [Abstract][Full Text] [Related]
7. Upper airway disease diagnosis as a predictive biomarker of therapeutic response to biologics in severe asthma.
Cottin S; Doyen V; Pilette C
Front Med (Lausanne); 2023; 10():1129300. PubMed ID: 37035303
[TBL] [Abstract][Full Text] [Related]
8. Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function.
Mansur AH; Srivastava S; Sahal A
Respir Med; 2018 Oct; 143():31-38. PubMed ID: 30261989
[TBL] [Abstract][Full Text] [Related]
9. Low-grade disease activity in early life precedes childhood asthma and allergy.
Chawes BL
Dan Med J; 2016 Aug; 63(8):. PubMed ID: 27477800
[TBL] [Abstract][Full Text] [Related]
10. Use of FeNO to predict anti-IL-5 and IL-5R biologics efficacy in a real-world cohort of adults with severe eosinophilic asthma.
Menigoz C; Dirou S; Chambellan A; Hassoun D; Moui A; Magnan A; Blanc FX
J Asthma; 2023 Jun; 60(6):1162-1170. PubMed ID: 36301080
[TBL] [Abstract][Full Text] [Related]
11. Predictive Biomarkers for Asthma Therapy.
Medrek SK; Parulekar AD; Hanania NA
Curr Allergy Asthma Rep; 2017 Sep; 17(10):69. PubMed ID: 28929293
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice.
Woo SD; Park HS; Jang JH; Lee Y; Yang EM; Ban GY; Kim SH; Shin YS; Ye YM; Park HS
Ann Allergy Asthma Immunol; 2023 Aug; 131(2):209-216.e2. PubMed ID: 37209833
[TBL] [Abstract][Full Text] [Related]
13. Airway Inflammation and Inflammatory Biomarkers.
Lim HF; Nair P
Semin Respir Crit Care Med; 2018 Feb; 39(1):56-63. PubMed ID: 29427986
[TBL] [Abstract][Full Text] [Related]
14. Sputum transcriptomics reveal upregulation of IL-1 receptor family members in patients with severe asthma.
Rossios C; Pavlidis S; Hoda U; Kuo CH; Wiegman C; Russell K; Sun K; Loza MJ; Baribaud F; Durham AL; Ojo O; Lutter R; Rowe A; Bansal A; Auffray C; Sousa A; Corfield J; Djukanovic R; Guo Y; Sterk PJ; Chung KF; Adcock IM;
J Allergy Clin Immunol; 2018 Feb; 141(2):560-570. PubMed ID: 28528200
[TBL] [Abstract][Full Text] [Related]
15. Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry.
Denton E; Price DB; Tran TN; Canonica GW; Menzies-Gow A; FitzGerald JM; Sadatsafavi M; Perez de Llano L; Christoff G; Quinton A; Rhee CK; Brusselle G; Ulrik C; Lugogo N; Hore-Lacy F; Chaudhry I; Bulathsinhala L; Murray RB; Carter VA; Hew M
J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2680-2688.e7. PubMed ID: 33744476
[TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).
Petsky HL; Cates CJ; Lasserson TJ; Li AM; Turner C; Kynaston JA; Chang AB
Thorax; 2012 Mar; 67(3):199-208. PubMed ID: 20937641
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.
Silkoff PE; Laviolette M; Singh D; FitzGerald JM; Kelsen S; Backer V; Porsbjerg C; Girodet PO; Berger P; Kline JN; Khatri S; Chanez P; Susulic VS; Barnathan ES; Baribaud F; Loza MJ;
Respir Res; 2016 Apr; 17():43. PubMed ID: 27107814
[TBL] [Abstract][Full Text] [Related]
18. Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs.
Parulekar AD; Kao CC; Diamant Z; Hanania NA
Curr Opin Pulm Med; 2018 Jan; 24(1):50-55. PubMed ID: 29036019
[TBL] [Abstract][Full Text] [Related]
19. Pragmatic Clinical Perspective on Biologics for Severe Refractory Type 2 Asthma.
Chan R; RuiWen Kuo C; Lipworth B
J Allergy Clin Immunol Pract; 2020; 8(10):3363-3370. PubMed ID: 32673880
[TBL] [Abstract][Full Text] [Related]
20. Multidimensional Assessment of Asthma Identifies Clinically Relevant Phenotype Overlap: A Cross-Sectional Study.
Han YY; Zhang X; Wang J; Wang G; Oliver BG; Zhang HP; Kang Y; Wang L; Qiu ZX; Li WM; Wang G
J Allergy Clin Immunol Pract; 2021 Jan; 9(1):349-362.e18. PubMed ID: 32791248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
